@ patients in the @-week group and @ in the @-week group had adverse events , the most common being death ( @ -LSB- @ % -RSB- in the @-week group vs @ -LSB- @ % -RSB- in the @-week group ) , antibiotic intolerance ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) , cardiorespiratory failure ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) , and neurological complications ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) .